GLSI6:00 AMGreenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01greenwichlifesciences.com
GLSI8:15 AMGreenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026Presentation / Abstract • Phase 3ASCO poster presentation Mon, Jun 1, 2026, 1:30 PM CTGgreenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Provides Update Regarding Form 10-K FilingPresentation / Abstract • Phase 3AACR poster presentation Wed, Apr 1, 2026greenwichlifesciences.com
GLSI4:30 PMGreenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filinggreenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Provides Update Regarding Form 10-K FilingInterim Data • Phase 3greenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026Presentation / Abstract • Phase 3greenwichlifesciences.com
GLSI5:00 PMGreenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filinggreenwichlifesciences.com
GLSI6:00 AMGreenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026Presentation / Abstract • Phase 3greenwichlifesciences.com